FDA Inspection 1122161 — Jonathan M Spergel MD PhD
The FDA completed an inspection of Jonathan M Spergel MD PhD on March 12, 2020 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Sponsor-Investigator (S-I)